An Important Message From CEO & President Dr. Magali Haas
Dear Friends, Family, and Colleagues,
Though veterans are at the heart of our work all year round, on Veterans Day we are reminded even more powerfully of all that they give and accomplish, as well as the burdens that many of them bear as a result of their service.
This year I want to draw your attention to an important op-ed piece recently published in the Military Times. It was written by our Veterans Advisory Council (VAC), which is chaired by Frank Larkin, former U.S. Senate Sergeant at Arms, and led by RADM Brian Losey, USN (Ret.) SEAL, Executive Director in partnership with VADM Bob Harward, USN (Ret.), SEAL; Robin King, CEO, Navy Seal Foundation; LTG John F. Mulholland, U.S. Army (Ret.), Special Forces; and Gayle Tzemach-Lemmon, author.
The op-ed opens by observing how easy it is for people to say to veterans, “Thank you for your service”—yet what veterans and service members really need is for us to take action on behalf of the too many veterans and service members whose lives are tragically altered or cut short by traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and other “invisible wounds.” We are especially failing the 1.64 million Americans deployed as part of Operation Enduring Freedom (OEF), in Afghanistan, and Operation Iraqi Freedom (OIF), in Iraq, who have undergone nearly two decades of combat and suffered historic levels of brain injury.
The VA and DoD, says the op-ed, have an ethical obligation to mobilize a national call to arms for research into the invisible wounds of war. Citing specifics, the VAC members call on the VA and DoD to work with leaders from nonprofits, academia, and industry to evaluate and conduct clinical trials on emerging treatments that have been embraced by the veteran community but require further clinical evaluation. Those treatments that are shown to be effective should be deployed throughout the VA system. In addition, Congress should ensure that legislation aimed at enabling research innovation, including the Commander John Scott Hannon Mental Health Improvement Act, is fully implemented.
“It is time,” the op-ed continues, “to narrow the gap between ‘thank you for your service’ and the reality that we are falling short when it comes to those who have sacrificed so much for this nation.” It closes with, “Our brave men and women are counting on us to take our ‘thank you’ one step further to meaningful action that truly honors their sacrifice.”
CVB’s VAC is committed to evidence-driven approaches to developing effective treatments for the invisible wounds of war. The council represents and advocates for Veterans’ interests to CVB, its partners, and the broader community engaged in research on the prevention and treatment of brain trauma and related conditions.
As we reflect on the end of 20 years of war, this Veterans Day should be a time not only to honor the sacrifices made by our military men and women, but to double down on our resolve to advance the research and treatment they so desperately need and deserve.
Magali Haas, MD, PhD
CEO & President
Cohen Veterans Bioscience
|